Insulin aspart, recombinant Subcutaneous and Rifampin Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Rifampin Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: rifampin
Brand name: Rifadin, Rifadin IV, Rimactane
Synonyms: Rifampin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Rifampin Intravenous
- Insulin aspart, recombinant Subcutaneous-Rifampin Oral, Intravenous
- Insulin aspart, recombinant Subcutaneous-Rifampin, Isoniazid, and Pyrazinamide
- Insulin aspart, recombinant Subcutaneous-Rifamycin
- Insulin aspart, recombinant Subcutaneous-Rifamycin Sodium
- Insulin aspart, recombinant Subcutaneous-Rifapentine
- Rifampin Injection-Insulin degludec
- Rifampin Injection-Insulin Degludec (U-100) Prefilled Pens
- Rifampin Injection-Insulin Degludec (U-100) Vials
- Rifampin Injection-Insulin Degludec (U-200) Prefilled Pens
- Rifampin Injection-Insulin degludec and liraglutide
- Rifampin Injection-Insulin degludec and liraglutide Subcutaneous